Lodosyn
PubChem Notes:
Carbidopa An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.
Molecular Formula:
C
10
H
16
N
2
O
5
InChI:
InChI=1/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/f/h15H;
InChIKey:
InChIKey=QTAOMKOIBXZKND-PGMRYZJXCQ
SMILES:
CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O
Names:
Carbidopa (JP15/USP)
carbidopa
D00558
Lodosyn (TN)
Lodosyn
3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methyl-propanoic acid hydrate
38821-49-7
Registries:
PubChem CID 441291
PubChem ID 7847624